CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia

about

CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia

Item

http://www.wikidata.org/entity/Q58237073

description

scientific article published on 01 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

CLT030, a leukemic stem cell-t ...... ment of acute myeloid leukemia

@en

CLT030, a leukemic stem cell-t ...... ment of acute myeloid leukemia

@nl

type

Item

label

CLT030, a leukemic stem cell-t ...... ment of acute myeloid leukemia

@en

CLT030, a leukemic stem cell-t ...... ment of acute myeloid leukemia

@nl

prefLabel

CLT030, a leukemic stem cell-t ...... ment of acute myeloid leukemia

@en

CLT030, a leukemic stem cell-t ...... ment of acute myeloid leukemia

@nl

P1476

CLT030, a leukemic stem cell-t ...... ment of acute myeloid leukemia

@en

P2093

Bob Y Liu

http://www.w3.org/2001/XMLSchema#string

Eric D Hsi

http://www.w3.org/2001/XMLSchema#string

Gautam Banik

http://www.w3.org/2001/XMLSchema#string

Jeffrey Lin

http://www.w3.org/2001/XMLSchema#string

Jianqing Huang

http://www.w3.org/2001/XMLSchema#string

Jianyu Zhu

http://www.w3.org/2001/XMLSchema#string

Madhavi Mishra

http://www.w3.org/2001/XMLSchema#string

Quan Zheng

http://www.w3.org/2001/XMLSchema#string

Ramkumar Mandalam

http://www.w3.org/2001/XMLSchema#string

Ruoying Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Toxicity and management in CAR T-cell therapy

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.

Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells.

The basic principles of chimeric antigen receptor design.

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.

Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin

P304

1738-1749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOODADVANCES.2018020107

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jagath R Junutula

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30037800

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

6058235

http://www.w3.org/2001/XMLSchema#string